Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1. (Q42524653)

1 November 2017

Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1. (English)

1 reference

1 November 2017

3

L A Akslen

1 reference

1 November 2017

J B Arnes

1

1 reference

PubMed ID

18269588

1 November 2017

K Collett

series ordinal

2

1 reference

1 November 2017

1 February 2008

1 reference

1 November 2017

1 reference

1 November 2017

52

1 reference

1 November 2017

3

1 reference

1 November 2017

370-380

1 reference

Molecular portraits of human breast tumours

1 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Expression profiling predicts outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Critical update and emerging trends in epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva) and gefitinib (Iressa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

BRCA1 functions as a breast stem cell regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Characterization and chromosomal localization of the human proto-oncogene BMI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Stem cell pluripotency and transcription factor Oct4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Oct-4: gatekeeper in the beginnings of mammalian development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Tissue microarrays (TMAs) for high-throughput molecular pathology research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Epidermal growth factor receptor expression in 780 breast cancer patients: a reappraisal of the prognostic value based on an eight-year median follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Self-renewal and solid tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Stem cell-ness: a "magic marker" for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

Oct4 pseudogenes are transcribed in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

ErbB-receptors expression and survival in breast carcinoma: A 15-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02957.X

10.1111/J.1365-2559.2007.02957.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference

PubMed ID

18269588